Howard McLeod, PharmD, the medical director at the DeBartolo Family Personalized Medicine Institute at the University of South Florida Moffitt Cancer Center. He was formerly the Fred Eshelman Distinguished Professor of Pharmacogenomics and Individualized Therapy at the UNC Eshelman School of Pharmacy at the University of North Carolina at Chapel Hill and the director of the UNC Institute for Pharmacogenomics and Individualized Therapy.
McLeod completed research fellowship training in cancer pharmacology at St. Jude Children’s Research Hospital in Memphis and at the University of Glasgow in Scotland before becoming the director of the clinical pharmacology program at the Beatson Cancer Centre in Glasgow. He then became a senior lecturer in medicine and director of laboratory research for the oncology unit at the University of Aberdeen in Scotland. McLeod returned to the United States in 2000 to accept a position at Washington University in St. Louis, Missouri, where he was a professor in the Departments of Medicine, Pharmacology and Molecular Biology, and Genetics and director of the Siteman Cancer Center Pharmacology Core.